Who owns WVE? 13F holders and whale ownership
WVE is tracked across public portfolios in Whale Analyzer. This page answers who owns WVE, which top funds are buying WVE, aggregate disclosed value, and recent position changes based on public data. Peter Kolchinsky is the largest reported holder at $196M; the top five funds control 100.0% of reported ownership; institutions were net buying last quarter (3 increased, 0 reduced); the stock trades above the aggregate whale cost basis of $4.47. Top tracked holders include Peter Kolchinsky, Lee Ainslie, Baker Bros. Advisors, and Stanley Druckenmiller.
Continue to the live WVE dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Peter Kolchinsky 13F portfolio RA Capital Management holdings | $195.6M | 27.0M | Increased |
| Lee Ainslie 13F portfolio Maverick Capital holdings | $73.7M | 10.2M | Increased |
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $6.0M | 822.6K | Increased |
| Stanley Druckenmiller 13F portfolio Duquesne Family Office holdings | $1.3M | 173.0K | Held |
Ownership concentration
Reported ownership of WVE is highly concentrated across tracked institutions.
- Single largest holder: 70.7% of reported ownership
- Top 5 holders: 100.0%
- Top 10 holders: 100.0%
Whale activity this quarter
Across 4 tracked institutions, 3 increased, 1 held. Net positioning is net buying.
- Peter Kolchinsky — RA Capital Management ($195.6M) (▲ 48.2% qoq shares) · avg cost $5.08
- Lee Ainslie — Maverick Capital ($73.7M) (▲ 9.5% qoq shares) · avg cost $2.61
- Baker Bros. Advisors — Baker Bros. Advisors ($6.0M) (▲ 139.1% qoq shares) · avg cost $6.62
- Stanley Druckenmiller — Duquesne Family Office ($1.3M) (→ 0.0% qoq shares) · avg cost $7.76
Whale cost basis vs current price
The aggregate tracked cost basis is $4.47 versus a current price of $5.83, so WVE trades above its cost basis (+30.5%). Average unrealized P&L across tracked holders: 33%.
Sector positioning — Other
WVE sits within the Other sector alongside 670 other tracked names. Compare whale ownership across peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live WVE dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- ASND whale holders — ASCENDIS PHARMA A/S - ADR
- PCVX whale holders — VAXCYTE INC
- RYTM whale holders — RHYTHM PHARMACEUTICALS INC
- TYRA whale holders — TYRA BIOSCIENCES INC
- SION whale holders — SIONNA THERAPEUTICS INC
- EWTX whale holders — EDGEWISE THERAPEUTICS INC
- NAMSW whale holders — NEWAMSTERDAM PHARMA CO NV
- NUVL whale holders — NUVALENT INC-A
Learn more in Whale Analyzer Academy
Deepen your read on WVE with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns WVE stock?
Whale Analyzer tracks 4 public institutional holders of WVE with a combined reported value of $276.5M. See the holder table above for the largest tracked positions.
Which top funds are buying WVE?
Tracked institutions were net buying last quarter — 3 increased, 1 held. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is WVE ownership?
The top five tracked holders report 100.0% of aggregate ownership.
Is WVE above or below the whale cost basis?
The aggregate tracked cost basis is $4.47 versus a current price of $5.83 (+30.5%).
What does 13F ownership mean for WVE?
Use the interactive WVE dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.